BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31479042)

  • 1. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling.
    Gustavsen MT; Midtvedt K; Vethe NT; Robertsen I; Bergan S; Åsberg A
    Ther Drug Monit; 2020 Jun; 42(3):407-414. PubMed ID: 31479042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients.
    Vethe NT; Gustavsen MT; Midtvedt K; Lauritsen ME; Andersen AM; Åsberg A; Bergan S
    Ther Drug Monit; 2019 Oct; 41(5):607-614. PubMed ID: 31584926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients.
    Gustavsen MT; Midtvedt K; Robertsen I; Woillard JB; Debord J; Klaasen RA; Vethe NT; Bergan S; Åsberg A
    Clin Transl Sci; 2020 Nov; 13(6):1327-1335. PubMed ID: 32652886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-dependent predictable pharmacokinetic method for tacrolimus exposure monitoring in kidney transplant patients.
    Velickovic-Radovanovic R; Mikov M; Catic-Djordjevic A; Stefanovic N; Mitic B; Paunovic G; Cvetkovic T
    Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):95-102. PubMed ID: 24596067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.
    Aouam K; Chadli Z; Hammouda M; Fredj NB; Aloui S; May ME; Boughattas N; Skhiri H; Chaabane A
    Ther Drug Monit; 2015 Aug; 37(4):524-30. PubMed ID: 25627405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction.
    Mbughuni MM; Stevens MA; Langman LJ; Kudva YC; Sanchez W; Dean PG; Jannetto PJ
    J Appl Lab Med; 2020 May; 5(3):516-530. PubMed ID: 32445361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure.
    Saint-Marcoux F; Woillard JB; Jurado C; Marquet P
    Ther Drug Monit; 2013 Jun; 35(3):322-7. PubMed ID: 23666572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients-A Cross-Validation Study.
    Kindem IA; Bjerre A; Åsberg A; Midtvedt K; Bergan S; Vethe NT
    Ther Drug Monit; 2021 Jun; 43(3):371-375. PubMed ID: 33596033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.
    Stifft F; Vandermeer F; Neef C; van Kuijk S; Christiaans MHL
    Eur J Clin Pharmacol; 2020 May; 76(5):685-693. PubMed ID: 32020321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a limited sampling strategy to estimate area under the curve of tacrolimus in adult renal transplant patients.
    Armendáriz Y; Pou L; Cantarell C; Lopez R; Perelló M; Capdevila L
    Ther Drug Monit; 2005 Aug; 27(4):431-4. PubMed ID: 16044098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a 2-Point Limited Sampling Strategy to Predict the Tacrolimus Area-Under-the-12-Hour-Curve in Kidney Transplant Recipients.
    Vadcharavivad S; Susomboon T; Kulabusaya B; Avihingsanon Y; Praditpornsilpa K; Townamchai N
    Ther Drug Monit; 2016 Oct; 38(5):614-20. PubMed ID: 27328329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.
    Musuamba FT; Mourad M; Haufroid V; De Meyer M; Capron A; Delattre IK; Verbeeck RK; Wallemacq P
    Br J Clin Pharmacol; 2013 May; 75(5):1277-88. PubMed ID: 23072565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation.
    Cheung CY; van der Heijden J; Hoogtanders K; Christiaans M; Liu YL; Chan YH; Choi KS; van de Plas A; Shek CC; Chau KF; Li CS; van Hooff J; Stolk L
    Transpl Int; 2008 Feb; 21(2):140-5. PubMed ID: 17944802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
    Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
    Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.